Neo Medical

Neo Medical

Develops transformational value-based healthcare technologies for thoracolumbar functional fusion.

HQ location
Bourg-en-Lavaux, Switzerland
Launch date
Employees
Enterprise value
$272—408m
Company register number
CHE-250.667.822
  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
*

$68.0m

Series B
Total Funding000k
Notes (0)
More about Neo Medical
Made with AI
Edit

Neo Medical SA, founded in 2013 by Jonas Larsson and Vincent Lefauconnier, is a Swiss medical technology company focused on advancing spinal surgery. The company's creation was fueled by Lefauconnier's two decades of experience in the spine industry, where he observed significant market growth without a corresponding improvement in patient outcomes. This frustration led to a "blank-slate approach" to redesign spinal surgery solutions. Lefauconnier, with a background in biology and marketing, previously held roles at Medtronic and Stryker and was the Chief Commercial Officer at Vexim, a startup acquired by Stryker. He met Larsson at Stryker, who had been developing the concepts for Neo Medical since 2012.

Operating in the thoracolumbar spine surgery market, which is valued at approximately $7.6 billion, Neo Medical provides its technology to surgeons and healthcare providers in Europe and the United States. The business model centers on selling a comprehensive platform of surgical products and digital tools. The company targets its solutions for a variety of spinal conditions, including degenerative disc disease, spinal stenosis, and traumatic injuries. A key milestone was the acquisition of its German commercial partner, TriOs Medical, in 2021 to strengthen its position in that market. Neo Medical has raised a total of $112 million over six financing rounds, with a significant $68 million Series B in September 2024 led by Gyrus Capital to fuel US expansion.

The company's core offering is the Neo Universal™ platform, an integrated ecosystem combining specialized hardware, procedural techniques, and digital solutions to facilitate more effective spinal fusion surgeries. This platform dramatically simplifies the surgical process, replacing traditional instrument sets of over 400 pieces with just five multi-functional instruments and a streamlined set of universal implants. The hardware includes 3D-printed titanium mesh cages and advanced screw systems. A key digital component is ADVISE™, an AI-driven, augmented reality platform that provides surgeons with real-time intraoperative data on an iPad to support personalized treatments. This integrated approach has been shown to reduce surgical time by up to 29%, cut infection risk by 50%, and lower implant failure rates, which can decrease the need for revision surgeries by as much as 50%. The products are sterile, single-use, and pre-packaged, which improves efficiency and reduces the hospital's environmental footprint.

Keywords: spinal surgery, medtech, spine fusion, augmented reality surgery, surgical instruments, orthopedic implants, value-based care, thoracolumbar fixation, patient-specific care, surgical robotics, AI in surgery, medical devices, minimally invasive surgery, spine technology, controlled fixation, ADVISE platform, Neo Universal, surgical efficiency, digital health, orthopedic technology, spine care, surgical navigation, implant technology

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo